Rational Vaccines Receives UK MHRA Innovation Passport for RVx201 for the Treatment of Genital Herpes Resulting From Herpes Simplex Type 2 (HSV-2) Virus

WOBURN, Mass. and OXFORD, U.K., July 22, 2021 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment of herpes to eradicate the disease, today announced that it has been awarded an Innovation Passport under a new process in the United Kingdom (UK) to bring...

from PR Newswire: https://ift.tt/3iAgcX3